Tetanus-diphtheria-pertussis immunization in pregnant women and the prevention of pertussis in young infants (Q46354787)

21 December 2017

editorial

0 references

title

Tetanus-diphtheria-pertussis immunization in pregnant women and the prevention of pertussis in young infants (English)

1 reference

21 December 2017

0 references

1 reference

1 reference

James D Cherry

1

1 reference

21 December 2017

language of work or name

English

0 references

publication date

19 October 2014

1 reference

21 December 2017

Clinical Infectious Diseases

published in

1 reference

21 December 2017

volume

60

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

338-340

1 reference

21 December 2017

A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Pertussis vaccine uptake during pregnancy: we need to do better in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Pertussis: challenges today and for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Waning protection after fifth dose of acellular pertussis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Maternal and neonatal vaccination protects newborn baboons from pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Pathogenesis and histopathology of pertussis: implications for immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Characteristics of Severe Bordetella pertussis Infection Among Infants ≤90 Days of Age Admitted to Pediatric Intensive Care Units - Southern California, September 2009-June 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

Safety of pertussis vaccination in pregnant women in UK: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU823

21 January 2018

Identifiers

DOI

10.1093/CID/CIU823

1 reference

21 December 2017

1 reference

21 December 2017